Research

• Select this article
  • Sandra Valéria de Sá,
  • Maria Lúcia Corrêa-Giannella,
  • Márcio Carlos Machado,
  • Jean Jorge S de Souza,
  • Maria Adelaide Albergaria Pereira,
  • Rosely Antunes Patzina,
  • Sheila Aparecida Coelho Siqueira,
  • Marcel Cerqueira César Machado,
  • and Daniel Giannella-Neto

  Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas

  Endocr Relat Cancer 13 (1) 69-78, doi:10.1677/erc.1.00962
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • G Galli,
  • R Zonefrati,
  • A Gozzini,
  • C Mavilia,
  • V Martineti,
  • I Tognarini,
  • G Nesi,
  • T Marcucci,
  • F Tonelli,
  • M Tommasi,
  • C Casini Raggi,
  • P Pinzani,
  • and M L Brandi

  Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma

  Endocr Relat Cancer 13 (1) 79-93, doi:10.1677/erc.1.00988
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Eric Ueda,
  • Ugur Ozerdem,
  • Yen-Hao Chen,
  • Min Yao,
  • Kuang Tzu Huang,
  • Huiqin Sun,
  • Manuela Martins-Green,
  • Paolo Bartolini,
  • and Ameae M Walker

  A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone

  Endocr Relat Cancer 13 (1) 95-111, doi:10.1677/erc.1.01076
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Susan M Dougherty,
  • Williard Mazhawidza,
  • Aimee R Bohn,
  • Krista A Robinson,
  • Kathleen A Mattingly,
  • Kristy A Blankenship,
  • Mary O Huff,
  • William G McGregor,
  • and Carolyn M Klinge

  Gender difference in the activity but not expression of estrogen receptors α and β in human lung adenocarcinoma cells

  Endocr Relat Cancer 13 (1) 113-134, doi:10.1677/erc.1.01118
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Michael Höpfner,
  • Viola Baradari,
  • Alexander Huether,
  • Christof Schöfl,
  • and Hans Scherübl

  The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours

  Endocr Relat Cancer 13 (1) 135-149, doi:10.1677/erc.1.01090
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Ta-Chun Yuan,
  • Suresh Veeramani,
  • Fen-Fen Lin,
  • Dmitry Kondrikou,
  • Stanislav Zelivianski,
  • Tsukasa Igawa,
  • Dev Karan,
  • Surinder K. Batra,
  • and Ming-Fong Lin

  Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells

  Endocr Relat Cancer 13 (1) 151-167, doi:10.1677/erc.1.01043
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • K-M Fung,
  • E N S Samara,
  • C Wong,
  • A Metwalli,
  • R Krlin,
  • B Bane,
  • C Z Liu,
  • J T Yang,
  • J V Pitha,
  • D J Culkin,
  • B P Kropp,
  • T M Penning,
  • and Hsueh-Kung Lin

  Increased expression of type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma

  Endocr Relat Cancer 13 (1) 169-180, doi:10.1677/erc.1.01048
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • S Humez,
  • M Monet,
  • G Legrand,
  • G Lepage,
  • P Delcourt,
  • and N Prevarskaya

  Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells

  Endocr Relat Cancer 13 (1) 181-195, doi:10.1677/erc.1.01079
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Adriano Angelucci,
  • Giovanni Luca Gravina,
  • Nadia Rucci,
  • Danilo Millimaggi,
  • Claudio Festuccia,
  • Paola Muzi,
  • Anna Teti,
  • Carlo Vicentini,
  • and Mauro Bologna

  Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice

  Endocr Relat Cancer 13 (1) 197-210, doi:10.1677/erc.1.01100
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Link to Commentary
• Select this article
  • Ki-Yon Kim,
  • Kyung-Chul Choi,
  • Nelly Auersperg,
  • and Peter C K Leung

  Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway

  Endocr Relat Cancer 13 (1) 211-220, doi:10.1677/erc.1.01033
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • F Castiglioni,
  • E Tagliabue,
  • M Campiglio,
  • S M Pupa,
  • A Balsari,
  • and S Ménard

  Role of exon-16-deleted HER2 in breast carcinomas

  Endocr Relat Cancer 13 (1) 221-232, doi:10.1677/erc.1.01047
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • T Suzuki,
  • S Hayashi,
  • Y Miki,
  • Y Nakamura,
  • T Moriya,
  • A Sugawara,
  • T Ishida,
  • N Ohuchi,
  • and H Sasano

  Peroxisome proliferator-activated receptor γ in human breast carcinoma: a modulator of estrogenic actions

  Endocr Relat Cancer 13 (1) 233-250, doi:10.1677/erc.1.01075
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • K L Cheung,
  • R Owers,
  • and J F R Robertson

  Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre

  Endocr Relat Cancer 13 (1) 251-255, doi:10.1677/erc.1.01108
  • Abstract
  • Full Text
  • Full Text (PDF)
• Select this article
  • G Riesco-Eizaguirre,
  • P Gutiérrez-Martínez,
  • M A García-Cabezas,
  • M Nistal,
  • and P Santisteban

  The oncogene BRAF^V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na⁺/I⁻ targeting to the membrane

  Endocr Relat Cancer 13 (1) 257-269, doi:10.1677/erc.1.01119
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only